DERM Journey Medical Corp: institutional ownership and insider trading

72 funds reported holding $78.7M of Journey Medical Corp in their latest 13F filings; in Q2 2026 funds net sold $8.82M, with 22 new positions and 23 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $68.2M and net income of −$6.10M.

DERM revenue and earnings

Famous investors holding DERM

Largest institutional holders of DERM

  1. WASATCH ADVISORS LP — $16.8M
  2. TANG CAPITAL MANAGEMENT LLC — $11.4M
  3. VANGUARD GROUP INC — $5.89M
  4. VANGUARD CAPITAL MANAGEMENT LLC — $4.78M
  5. PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. — $3.79M
  6. Pale Fire Capital SE — $3.74M
  7. Opaleye Management Inc. — $2.48M
  8. JANE STREET GROUP, LLC — $2.47M
  9. Summit Financial, LLC — $2.45M
  10. Diametric Capital, LP — $2.09M

Recent DERM insider trades

5%+ owners

Who owns the most DERM stock?

The largest institutional holders of Journey Medical Corp in the latest 13F filings are WASATCH ADVISORS LP ($16.8M), TANG CAPITAL MANAGEMENT LLC ($11.4M), VANGUARD GROUP INC ($5.89M).

Are insiders buying or selling DERM?

No open-market insider buys or sells of Journey Medical Corp were reported in the last 12 months.

Which famous investors own DERM?

Renaissance Technologies, Izzy Englander, Ken Griffin.

What was DERM's revenue last quarter?

Journey Medical Corp reported revenue of $18.5M for the quarter ended June 30, 2026, with net income of −$312K.

Which ETFs hold DERM?

2 ETFs and mutual funds hold it among their top 100 positions, including WGICX, WAMVX.

All DERM 13F holders · All DERM insider trades